Physician profile
Thomas C Wilson
NPI 1184064834
$1,291.92
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $68.04 · 2021: $55.46 · 2022: $269 · 2023: $414 · 2024: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $304.78 | 2023 | Distal Extremities Implants Foot & Ankle Cfs |
| Horizon Therapeutics Plc | $196.53 | 2019-2022 | |
| Smith+Nephew, INC. | $169.01 | 2019-2022 | |
| Stryker Corporation | $138.01 | 2022 | |
| Paratek Pharmaceuticals, INC. | $109.58 | 2023 | Nuzyra |
| Amgen INC. | $98.85 | 2024 | Krystexxa |
| Organogenesis INC. | $89.57 | 2019-2021 | |
| Bioventus LLC | $75.00 | 2019 | |
| Osiris Therapeutics INC. | $38.45 | 2019 | |
| Integra Lifesciences Corporation | $19.16 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Misonix INC | $15.07 | 2020 | |
| 3m Company | $13.66 | 2019 | |
| Bsn Medical INC | $12.85 | 2019 | |
| Kci USA, INC. | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.